Go Deep
Turn Therapeutics Inc.
Turn Therapeutics Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | -231,761 | -38.3 | 491.18 | 8.91 | 1,054.87 |
| Oct 2026 | -242,518 | -38.6 | 512.40 | 8.91 | 1,100.60 |
| Oct 2026 | -219,658 | -36.4 | 467.31 | 8.91 | 1,001.14 |
| Oct 2026 | -223,468 | -37.0 | 474.82 | 8.91 | 1,018.33 |
| Oct 2026 | -217,417 | -36.1 | 462.88 | 8.91 | 992.73 |
| Oct 2026 | -210,284 | -35.0 | 448.74 | 8.91 | 960.01 |
| Oct 2026 | -210,956 | -35.1 | 450.06 | 8.91 | 960.90 |
Turn Therapeutics Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -5,849,734.0 | -970,972.0 | 279,070.0 | -1,904,184.0 |
| EPS | -0.2 | -0.0 | — | -0.1 |
Turn Therapeutics Inc. Revenue & Profit: Last 3 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 |
| Net Profit | -3,194,080.0 | -1,768,415.0 | -2,292,267.0 |
| EPS | -0.1 | -0.1 | -0.1 |
Turn Therapeutics Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Total Assets | 12,162,241.0 | 2,048,889.0 | 2,013,560.0 |
| Total Liabilities | 7,475,518.0 | 2,226,321.0 | 1,927,792.0 |
| Total Equity | 4,686,723.0 | -177,432.0 | 85,768.0 |
Owes vs Owns
Turn Therapeutics Inc. owed $0.96 for every $1 it owned in Jun 2026, about the same as $0.96 in Dec 2023.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.96× | 0.61× | 1.09× | 0.96× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Turn Therapeutics Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 41.7%Fixed assets (tangible) 0.6%Intangible assets 7.6%Other assets 50.0%
How it's funded — Dec 2025
Payables 24.1%Other liabilities 36.7%Shareholders' equity 38.5%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Assets | |||
| Cash & short-term investments | 5.1 | 0.9 | 1.2 |
| Receivables | 0.0 | 0.0 | 0.0 |
| Inventory | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.1 | 0.1 | 0.0 |
| Intangible assets | 0.9 | 0.8 | 0.8 |
| Long-term investments | 0.0 | 0.0 | 0.0 |
| Other assets | 6.1 | 0.2 | 0.0 |
| Liabilities & equity | |||
| Short-term debt | 0.0 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.1 | 0.0 |
| Payables | 2.9 | 0.7 | 0.5 |
| Other liabilities | 4.5 | 1.4 | 1.4 |
| Shareholders' equity | 4.7 | -0.2 | 0.1 |
| Net tangible assets | 3.8 | -1.0 | -0.7 |
Turn Therapeutics Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|---|
| Operating Activities | -2,562,901.0 | -1,361,305.0 | -1,377,680.0 |
| Investing Activities | -152,986.0 | -99,475.0 | -44,306.0 |
| Financing Activities | 6,919,432.0 | 1,152,382.0 | 500,000.0 |